Results 141 to 150 of about 48,421 (285)

Cardiac amyloidosis in a Swiss autopsy cohort – distribution and clinical relevance

Swiss Medical Weekly
AIMS: Cardiac amyloidosis (CA) characterised by myocardial amyloid accumulation is likely underdiagnosed. The distribution and extent of myocardial amyloid deposits remain unclear.
Albert Baschong, Sara Ersözlü, Frank Ruschitzka, Andreas J. Flammer, Christoph A. Meier, Zsuzsanna Varga, Holger Moch, Umberto Maccio   +7 more
doaj   +1 more source

Meta‐Analysis: Prevalence and Incidence of Gastroparesis Following Lung or Heart Transplantation

Alimentary Pharmacology &Therapeutics, Volume 63, Issue 10, Page 1348-1359, May 2026.
Gastroparesis occurs in nearly one‐third of lung and heart‐lung transplant recipients (pooled prevalence 31.9%; incidence 25.7%), driven by surgical complexity, perioperative opioid exposure, and diagnostic criteria. Standardized gastric emptying assessment and multidisciplinary management, including opioid minimization, immunosuppressant optimization,
Mohamed H. Eldesouki, Mohamed Mahmoud Marey, Mohamed Ahmed Ali, Amany Mahmoud Genidy, Mohamed Hesham Gamal, Ali M. Othman, Ahmed N. Mohamed, Ahmed Al Qady, Manuel A. Amaris, Amol Sharma   +9 more
wiley   +1 more source

Cardiac Amyloidosis: A Narrative Review of Diagnostic Advances and Emerging Therapies

Biomedicines
Background/Objectives: Cardiac amyloidosis (CA) is an underdiagnosed and potentially life-threatening infiltrative cardiomyopathy characterized by the extracellular deposition of misfolded amyloid fibrils in cardiac tissue. It is most commonly associated
Dana Emilia Movila, Alexandru Catalin Motofelea, Dragos Cozma, Oana Albai, Alexandra Christa Sima, Minodora Andor, Tudor Ciocarlie, Simona Ruxanda Dragan   +7 more
doaj   +1 more source

ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 2 of 2—Diagnostic criteria and appropriate utilization [PDF]

, 2019
Sharmila Dorbala, Yukio Ando, Sabahat Bokhari, Angela Dispenzieri, Rodney H. Falk, Victor A. Ferrari, Marianna Fontana, Olivier Gheysens, Julian D. Gillmore, Andor W.J.M. Glaudemans, Mazen Hanna, Bouke P. C. Hazenberg, Arnt V. Kristen, Raymond Y. Kwong, Matthew J. Maurer, Giampaolo Merlini, Edward J. Miller, James Moon, Venkatesh L. Murthy, Cristina Quarta, Claudio Rapezzi, Frederick L. Ruberg, Sanjiv J. Shah, Riemer H. J. A. Slart, Hein J. Verberne, Jamieson M. Bourque   +25 more
openalex   +1 more source

Concurrence of the Core Mechanistic Tenets of the American Heart Association Statement on the Cardiovascular–Kidney–Metabolic Syndrome and the Adipokine Hypothesis of Heart Failure With Preserved Ejection Fraction

Diabetes, Obesity and Metabolism, Volume 28, Issue 6, Page 4432-4436, June 2026.
Milton Packer
wiley   +1 more source

True, true unrelated? Coexistence of Waldenström macroglobulinemia and cardiac transthyretin amyloidosis

Haematologica, 2018
Avinainder Singh, Hallie I. Geller, Kevin M. Alexander, Robert F. Padera, Richard N. Mitchell, Sharmila Dorbala, Jorge J. Castillo, Rodney H. Falk   +7 more
doaj   +1 more source

Untangling the clinical and economic burden of hospitalization for cardiac amyloidosis in the United States

ClinicoEconomics and Outcomes Research, 2019
Tiffany P Quock,1 Tingjian Yan,2 Ryan Tieu,2 Anita D’Souza,3 Michael S Broder21Medical Affairs, Prothena Biosciences Inc, South San Francisco, CA, USA; 2Health Services Research, Partnership for Health Analytic Research, LLC, Beverly Hills, CA, USA;
Quock TP, Yan T, Tieu R, D'Souza A, Broder MS   +4 more
doaj  

A propensity-matched analysis of cardiac operation in patients with and without cardiac amyloidosisCentral MessagePerspective

JTCVS Open
Objective: There are limited data on the outcome of routine cardiac operations in patients with cardiac amyloidosis. This study studied the impact of amyloidosis on early and late results of cardiac operations.
Akshay Chauhan, MBBS, Kevin L. Greason, MD, Daniel D. Borgeson, MD, Austin Todd, MS, John M. Stulak, MD, Richard C. Daly, MD, Juan A. Crestanello, MD, Hartzell V. Schaff, MD   +7 more
doaj   +1 more source

End-Stage Renal Disease in Familial Amyloidosis ATTR Val30Met: A [PDF]

, 2003
Transplant Proc. 2003 May;35(3):1116-20. End-stage renal disease in familial amyloidosis ATTR Val30Met: a definitive indication to combined liver-kidney transplantation.
Beirão, I., Henriques, A.C., Lobato, L., Miranda, H.P., Pereira, M.C., Sarmento, A.M., Seca, R., Teixeira, M., Ventura, A.   +8 more
core  

Combined Cardiac and Liver Transplantation for the Treatment of Familial Amyloidosis [PDF]

, 2007
Brian Schwartz, Johannes J. Kuiper, Göran B. Klintmalm, Marvin J. Stone, Jeffrey Schussler   +4 more
openalex   +1 more source